1. Home
  2. EYPT vs HTBK Comparison

EYPT vs HTBK Comparison

Compare EYPT & HTBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • HTBK
  • Stock Information
  • Founded
  • EYPT 1987
  • HTBK 1997
  • Country
  • EYPT United States
  • HTBK United States
  • Employees
  • EYPT N/A
  • HTBK N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • HTBK Major Banks
  • Sector
  • EYPT Industrials
  • HTBK Finance
  • Exchange
  • EYPT Nasdaq
  • HTBK Nasdaq
  • Market Cap
  • EYPT 579.4M
  • HTBK 588.2M
  • IPO Year
  • EYPT 2005
  • HTBK 1998
  • Fundamental
  • Price
  • EYPT $10.48
  • HTBK $9.58
  • Analyst Decision
  • EYPT Strong Buy
  • HTBK Buy
  • Analyst Count
  • EYPT 8
  • HTBK 3
  • Target Price
  • EYPT $24.75
  • HTBK $11.33
  • AVG Volume (30 Days)
  • EYPT 729.0K
  • HTBK 531.2K
  • Earning Date
  • EYPT 08-06-2025
  • HTBK 07-24-2025
  • Dividend Yield
  • EYPT N/A
  • HTBK 5.41%
  • EPS Growth
  • EYPT N/A
  • HTBK N/A
  • EPS
  • EYPT N/A
  • HTBK 0.63
  • Revenue
  • EYPT $56,042,000.00
  • HTBK $180,089,000.00
  • Revenue This Year
  • EYPT N/A
  • HTBK $9.79
  • Revenue Next Year
  • EYPT N/A
  • HTBK $6.00
  • P/E Ratio
  • EYPT N/A
  • HTBK $15.26
  • Revenue Growth
  • EYPT 12.04
  • HTBK 3.15
  • 52 Week Low
  • EYPT $3.91
  • HTBK $8.09
  • 52 Week High
  • EYPT $13.99
  • HTBK $11.27
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 59.34
  • HTBK 36.49
  • Support Level
  • EYPT $10.26
  • HTBK $10.08
  • Resistance Level
  • EYPT $11.00
  • HTBK $10.53
  • Average True Range (ATR)
  • EYPT 0.64
  • HTBK 0.20
  • MACD
  • EYPT -0.07
  • HTBK -0.11
  • Stochastic Oscillator
  • EYPT 42.11
  • HTBK 10.57

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.

Share on Social Networks: